% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Quattrone:277727,
author = {Quattrone, Andrea and Franzmeier, Nicolai and Levin,
Johannes and Petzold, Gabor C and Spottke, Annika and
Brosseron, Frederic and Falkenburger, Björn and Prudlo,
Johannes and Gasser, Thomas and Höglinger, Günter U},
collaboration = {DESCRIBE-PSP Group, The ProPSP Group},
othercontributors = {Petzold, Gabor C and Kimmich, Okka and Falkenburger, Björn
and Dinter, Elisabeth and Höglinger, Günter and Palleis,
Carla and Bernhardt, Alexander Maximilian and Levin,
Johannes and Katzdobler, Sabrina and Jäck, Alexander and
Prudlo, Johannes and Gasser, Thomas and Brockmann, Kathrin
and Spottke, Annika and Gamez, Anna and Brosseron, Frederic
and Klietz, Martin and Wegner, Florian and Pötter-Nerger,
Monika and Pedrosa, David J and Eggers, Carsten and
Mollenhauer, Brit and Claus, Inga and Regensburger, Martin
and Süß, Patrick and Warnecke, Tobias and Gandor, Florin
and Gruber, Doreen and Berg, Daniela and Paschen, Steffen
and Claßen, Joseph and Kassubek, Jan and Jost, Wolfgang H
and Tönges, Lars},
title = {{P}rospective {M}ulticenter {E}valuation of the {MDS}
'{S}uggestive of {PSP}' {D}iagnostic {C}riteria.},
journal = {Movement disorders},
volume = {40},
number = {3},
issn = {0885-3185},
address = {New York, NY},
publisher = {Wiley},
reportid = {DZNE-2025-00448},
pages = {526 - 536},
year = {2025},
abstract = {The recent Movement Disorders Society (MDS)-progressive
supranuclear palsy (PSP) diagnostic criteria conceptualized
three clinical diagnostic certainty levels: 'suggestive of
PSP' for sensitive early diagnosis based on subtle clinical
signs, 'possible PSP' balancing sensitivity and specificity,
and 'probable PSP' highly specific for PSP pathology.The aim
of this study was to prospectively validate the criteria
against long-term clinical follow-up and characterize the
diagnostic certainty increase over time.Patients with
'possible PSP' or 'suggestive of PSP' diagnosis and clinical
follow-up were recruited in two German multicenter
longitudinal observational studies (ProPSP and DescribePSP).
The cumulative percentage of patients longitudinally
increasing diagnostic certainty was assessed over up to 2.5
years of follow-up. The sample size per arm required to
detect $30\%$ attenuated rate in diagnostic certainty
increase in trials was estimated over multiple time
intervals.Of 254 patients with available longitudinal data,
61 patients had low diagnostic certainty at baseline (48
suggestive of PSP, 13 possible PSP) and multiple clinical
visits (median: 3, range: 2-4). The cumulative percentage of
patients increasing diagnostic certainty progressed with
follow-up duration $(30.4\%$ at 6 months, $51.7\%$ at 1
year, $80.4\%$ at 2.5 years). The sample size required to
detect $30\%$ reduction in diagnostic certainty increase
rate within 1 year was 163, slightly smaller than that
required using the PSP rating scale.Most 'suggestive of PSP'
patients increased diagnostic certainty upon longitudinal
follow-up, providing the first prospective multicenter
validation of MDS-PSP diagnostic criteria. Our data support
the design of trials tailored for these early-stage
patients, suggesting the PSP rating scale and the diagnostic
certainty increase rate as potential endpoint measures. ©
2025 The Author(s). Movement Disorders published by Wiley
Periodicals LLC on behalf of International Parkinson and
Movement Disorder Society.},
keywords = {Humans / Supranuclear Palsy, Progressive: diagnosis /
Female / Male / Aged / Middle Aged / Longitudinal Studies /
Prospective Studies / Sensitivity and Specificity / Aged, 80
and over / diagnostic criteria (Other) / longitudinal
(Other) / progressive supranuclear palsy (Other) /
suggestive of PSP (Other) / validation (Other)},
cin = {Clinical Research (Munich) / AG Levin / AG Petzold / AG
Spottke / AG Heneka / AG Falkenburger / AG Teipel / AG
Gasser},
ddc = {610},
cid = {I:(DE-2719)1111015 / I:(DE-2719)1111016 /
I:(DE-2719)1013020 / I:(DE-2719)1011103 / I:(DE-2719)1011303
/ I:(DE-2719)1710012 / I:(DE-2719)1510100 /
I:(DE-2719)1210000},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
experiment = {EXP:(DE-2719)DESCRIBE-PSP-20160101},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:39797511},
pmc = {pmc:PMC11926504},
doi = {10.1002/mds.30112},
url = {https://pub.dzne.de/record/277727},
}